Drugs / 17α Hydroxyprogesterone Caproate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01317225 | Jun 2011 → Jul 2015 | obstetric disorder | Saint Thomas Hospital, Panama | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03130504 Comparator | Apr 2016 → Mar 2017 | — | Assiut University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 17α Hydroxyprogesterone Caproate | “17α-Hydroxyprogesterone caproate.” NCT01317225 ↗ |
| Route | Intramuscular | “250mg intramuscular (gluteal muscles) biweekly from enrollment until delivery.” NCT01317225 ↗ |